INTRATHECAL METHYSERGIDE ANTAGONIZES THE ANTINOCICEPTION, BUT NOT THEHYPERALGESIA PRODUCED BY MICROINJECTION OF BACLOFEN IN THE VENTROMEDIAL MEDULLA OF THE RAT
Dl. Hammond et al., INTRATHECAL METHYSERGIDE ANTAGONIZES THE ANTINOCICEPTION, BUT NOT THEHYPERALGESIA PRODUCED BY MICROINJECTION OF BACLOFEN IN THE VENTROMEDIAL MEDULLA OF THE RAT, Neuroscience letters, 244(2), 1998, pp. 93-96
Microinjection of baclofen, a gamma-aminobutyric acids (GABA(B)) recep
tor agonist, in the nucleus raphe magnus (NRM) or nucleus reticularis
gigantocellularis pars alpha (NGCp alpha) of the rat produces antinoci
ception at doses of 0.1-1.0 ng and hyperalgesia at doses of 30-150 ng
in the tail-flick test. The antinociception is proposed to result from
disinhibition oi spinally-projecting neurons in this region that cont
ain serotonin. The hyperalgesia is proposed to result either from inhi
bition of these neurons or from disinhibition of a serotonergic pain f
acilitatory pathway that also originates in this area of the ventromed
ial medulla. To determine the involvement of bulbospinal serotonergic
pathways in the biphasic effects of baclofen, rats were pretreated int
rathecally with either 30 mu g of methysergide or saline. Ten minutes
later, either saline, 0.5 ng or 150 ng of baclofen was microinjected i
n the NRM and NGCp alpha, and alterations in nociceptive threshold wer
e assessed by the tail-flick and hot-plate tests. Intrathecal pretreat
ment with methysergide prevented the increase in tail-flick latency pr
oduced by 0.5 ng of baclofen, but did not prevent the decrease in tail
-flick latency produced by 150 ng of baclofen. Neither dose of baclofe
n altered hot-plate latency and this lack of effect was unchanged by m
ethysergide. These data support the idea that the antinociceptive effe
ct of low doses of baclofen in the tail-flick test is mediated by disi
nhibition of a bulbospinal serotonergic projection and release of sero
tonin in the spinal cord. These data also suggest that the hyperalgesi
a produced by high doses of baclofen does not result from disinhibitio
n of a serotonergic pain facilitatory pathway, but rather from direct
inhibition of tonically-active pain inhibitory neurons in the NRM and
NGCp alpha. (C) 1998 Published by Elsevier Science Ireland Ltd.